Project Grant R01HD121569
- The National Institute of Child Health and Human Development awarded Yale University $456,999 on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the role of acetyl-methyllysine in spermatogenic development. The research characterizes the distribution and regulation of acetyl-methyllysine (KACME), a histone modification combining lysine acetylation and methylation, during sperm development. Aim 1 applies custom anti-KACME...
- The National Institute of Child Health and Human Development awarded Syracuse University $323,643 on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate molecular interactions between the female reproductive tract and sperm that determine fertility. The research characterizes female-derived metabolic proteins and their spatiotemporally regulated interactions with sperm during storage and transit in the female reproductive tract....
- The National Institute of Child Health and Human Development awarded Yale University $1.396 million on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate centromere integrity and cytoskeletal function in oocyte aneuploidy and reproductive aging. The award funds research using mouse oocytes to analyze how centromere proteins (including CENP-A and CENP-C), centromeric DNA composition, and microtubule-associated proteins interact to...
- The National Institute of Child Health and Human Development, part of the Department of Health and Human Services, awarded Yale University $5,063,609 on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate how antiretroviral therapy exposure during pregnancy disrupts immune development and placental function in HIV-exposed uninfected infants. The research will use immunopeptidomics, transcriptomics, and functional co-culture assays...
- The National Institute of Child Health and Human Development awarded Yale University $132,022 on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the role of histone H4 acetylation in mammalian embryogenesis and maternal aging. The research examines how epigenetic modifications, specifically H4K12ac (histone H4 lysine 12 acetylation), direct cellular transitions during early embryonic development and how dysregulation of these...
- The National Institute of Child Health and Human Development awarded Yale University $100,228 on December 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to define the function of tubulin post-translational modifications in female meiosis. The research investigates microtubule organization and chromosome segregation mechanisms in oocytes to probe the molecular origins of egg aneuploidy. The recipient will use mouse oocytes as a model of mammalian...
- The National Institute of Child Health and Human Development awarded the University of Massachusetts Medical School $716,119 on July 25, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate dietary signaling mechanisms in male reproductive tissues and their epigenetic effects on offspring. The project explores how paternal dietary exposures influence cell composition and gene regulation in the testis, epididymis, and seminal vesicle, and...
- The National Institute of Child Health and Human Development, part of the Department of Health and Human Services National Institutes of Health, awarded $456,500 to The University of Texas Southwestern Medical Center on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds molecular characterization of human pregnancy-induced cervical epithelium through two research aims. First, the recipient will apply single-cell and spatial...
- Yale University received a $460,625 Project Grant award dated August 11, 2025, from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The research initiative, with a completion date of July 31, 2027, focuses on elucidating the mechanisms of hematopoietic stem cell (HSC) development during fetal life in mice. The project addresses critical gaps in understanding how endothelial cells...
- The National Institute of Child Health and Human Development awarded the University of Toledo $448,793 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate spermatozoa head-kinking mechanics and their role in male fertility. The research addresses molecular and cellular mechanisms underlying human spermatozoa navigation and egg fertilization. The project will employ rabbits as a genetic model and high-resolution microscopy to...
The National Institute of Child Health and Human Development awarded Yale University $543,572 on August 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the molecular mechanisms of sperm-immune recognition in the female reproductive tract. The research addresses how resident macrophages in the female reproductive tract selectively eliminate compromised sperm while permitting viable sperm to reach the egg. The project focuses on IZUMO1, a sperm acrosomal membrane protein that serves as a natural ligand for a macrophage receptor and becomes surface-exposed only after acrosome reaction or when sperm are compromised. The research pursues three specific aims: determining high-resolution structures of the IZUMO1–macrophage receptor complex using structural biology approaches and mutagenesis studies; visualizing receptor-mediated sperm phagocytosis to capture ultrastructural details of sperm-macrophage interactions; and profiling the human antibody repertoire against IZUMO1 by isolating IZUMO1-reactive B cells from healthy women. The award represents $543,572 in obligated funding. Performance occurs in New Haven, Connecticut, with a completion date of April 30, 2031. The assistance type is Project Grant. This research addresses a documented gap in understanding immuno-infertility, a significant contributing factor in fertility problems affecting approximately 9 percent of men and 11 percent of women in the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $543.6k | 8/10/26 |